Nešić, M.D.; Dučić, T.; Algarra, M.; Popović, I.; Stepić, M.; Gonçalves, M.; Petković, M.
Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study. Cancers 2022, 14, 1182.
https://doi.org/10.3390/cancers14051182
AMA Style
Nešić MD, Dučić T, Algarra M, Popović I, Stepić M, Gonçalves M, Petković M.
Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study. Cancers. 2022; 14(5):1182.
https://doi.org/10.3390/cancers14051182
Chicago/Turabian Style
Nešić, Maja D., Tanja Dučić, Manuel Algarra, Iva Popović, Milutin Stepić, Mara Gonçalves, and Marijana Petković.
2022. "Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study" Cancers 14, no. 5: 1182.
https://doi.org/10.3390/cancers14051182
APA Style
Nešić, M. D., Dučić, T., Algarra, M., Popović, I., Stepić, M., Gonçalves, M., & Petković, M.
(2022). Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study. Cancers, 14(5), 1182.
https://doi.org/10.3390/cancers14051182
